Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-10-000740
Filing Date
2010-11-16
Accepted
2010-11-16 17:12:15
Documents
1
Group Members
CHARLES R. KAYEJOSEPH P. LANDYWARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS LLCWARBURG PINCUS X LLCWARBURG PINCUS X PARTNERS, L.P.WARBURG PINCUS X, L.P.

Document Format Files

Seq Description Document Type Size
1 4TH AMENDMENT w6000622b.htm SC 13D/A 215808
  Complete submission text file 0000899140-10-000740.txt   218077
Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Subject) CIK: 0001403132 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83350 | Film No.: 101197304
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017
Business Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017 212-878-0600
Warburg Pincus Private Equity X, L.P. (Filed by) CIK: 0001414565 (see all company filings)

EIN.: 200849130
Type: SC 13D/A